General information
Procord is an experimental cell therapy that is
being developed for the treatment of patients with a recent
spinal cord injury. Phase I clinical trials of the
experimental procedure were conducted from 2000 to 2003 in
Israel and Belgium. Since late 2003, Proneuron is sponsoring
a Phase II clinical trial at hospitals in the USA and
Israel.
Recruitment to the ProCord
clinical trial is currently suspended
We wish to make it clear that the reason for the suspension is
not
the result of any clinical or safety concerns. Clinical
follow-up is being continued on those patients already
enrolled in the study
Further details about Procord
Our
companion site at
www.spinalcordtrial.com
provides information for spinal cord injury patients, physicians and
anybody else who is interested in Procord.
